Search our website

Publications

Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells
February 8th, 2021
Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma
February 8th, 2021
Three decades of hepatitis B control with vaccination
February 8th, 2021
Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine
February 8th, 2021
Randomized Controlled Study Investigating Viral Suppression and Serological Response following Pre-S1/Pre-S2/S Vaccine Therapy Combined with Lamivudine Treatment in HBeAg-Positive Patients with Chronic Hepatitis B
February 8th, 2021
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity
February 8th, 2021
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
February 8th, 2021
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
February 8th, 2021
Rapid and high seroprotection rates achieved with a tri-antigenic hepatitis B vaccine in healthy young adults: Results from a Phase IV Study
February 8th, 2021

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up NowArrow
Go top